Andrx Pharmaceuticals, Inc.

ACETAMAX

NARCOTIC ANALGESIC PHARMACEUTICAL PREPARATION;

ANDAZOLE

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GASTRO INTESTINAL DISEASES AND DISORDERS;

CARDACOR

PHARMACEUTICAL PREPARATIONS INCLUDING THOSE CONTAINING DILTIAZEM HYDROCHLORIDE FOR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS;

CARDACOR XT

PHARMACEUTICAL PREPARATIONS INCLUDING THOSE CONTAINING DILTIAZEM HYDROCHLORIDE FOR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDER;

CARTIA XT

PHARMACEUTICAL PREPARATIONS INCLUDING THOSE CONTAINING DILTIAZEM HYDROCHLORIDE FOR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS;

CETAMAX

NARCOTIC ANALGESIC PHARMACEUTICAL PREPARATION;

CODENOL

PRESCRIPTION ORAL NARCOTIC ANALGESIC PHARMACEUTICAL PREPARATION;

CODINOL

prescription oral narcotic analgesic pharmaceutical preparation;

CODRIX

Prescription pharmaceutical preparations, namely dosage forms containing a combination of an opiod analgesic and non-steroidal anti-inflammatory drug;

CODRX

Prescription pharmaceutical preparations, namely dosage forms containing a combination of an opiod analgesic and non-steroidal anti-inflammatory drug;

DEPROVAL

PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF EPILEPSY, CONVULSION, OR MIGRAINE;

DEPROVEX

PHARMACEUTICAL PREPARATION FOR USE IN THE FIELD OF NEUROPSYCHIATRY;

DPHS

Development of new technologies for others in the field of pharmaceutical technologies for controlled release or delivery of pharmaceutical substances;

GMHS

DEVELOPMENT AND PREPARATION OF PHARMACEUTICAL FORMULATION SYSTEM, NAMELY A SYSTEM COMPRISING FORMULATIONS AND PROCEDURES FOR CONTROLLED RELEASE AND DELIVERY OF PHARMACEUTICAL SUBSTANCES;

JIANAP

Pharmaceutical preparation and substances, namely, anti-inflammatory, analgesic and antipyretic drugs;

KETO XT

pharmaceutical preparations including those containing ketoprofen for use in the treatment of arthritis;

LOVASTAT XT

pharmaceutical preparations including those containing lovastatin for use in the treatment of cardiovascular disorders;

NIFED XT

pharmaceutical preparations including those containing nifedipine for use in the treatment of cardiovascular disorders;

OMETRA

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GASTRO INTESTINAL DISEASES AND DISORDERS;

PELTAB

technical research, preparation and development of pharmaceutical formulations and procedures for the controlled release and delivery of medicinal substances;

PRAZOLE

PHARMACEUTICAL PREPARATIONS INCLUDING THOSE CONTAINING OMEPRAZOLE FOR USE IN THE TREATMENT OF DUODENAL ULCERS AND GASTROESOPHAGEAL REFLUX DISORDERS;

PRAZOLE XT

pharmaceutical preparations including those containing omeprazole for use in the treatment of duodenal ulcers and gastroesophageal reflux disorders;

PROMEZ

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GASTRO INTESTINAL DISEASES AND DISORDERS;

PROTIA

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GASTRO INTESTINAL DISEASES AND DISORDERS;

SCOT

RESEARCH AND DEVELOPMENT OF PHARMACEUTICAL TECHNOLOGIES FOR OTHERS USED FOR CONTROLLED RELEASE OR DELIVERY OF PHARMACEUTICAL SUBSTANCES, EXCLUDING PHARMACEUTICAL PACKING MADE OF GLASS OR PLASTIC, MICRO ARRAYS, BIOCHIPS, AND HIGH TECH SENSORS;

SPDS

Development and preparation of pharmaceutical formulation system, namely a system comprising formulations and procedures for controlled release and delivery of pharmaceutical substances;

STATIN XT

STATIN;pharmaceutical preparations including those containing lovastatin for use in the treatment of cardiovascular disorders;

TAZTIA XT

Pharmaceutical product for the treatment of Angina and Hypertension;

ZINIX

PHARMACEUTICAL PREPARATIONS, NAMELY, SUBSTANCES FOR THE TREATMENT AND PREVENTION OF DISEASES OF THE CENTRAL NERVOUS SYSTEM AND TO ASSIST IN THE CESSATION OF USE OF TOBACCO PRODUCTS;

ZYNIX

PHARMACEUTICAL PREPARATIONS, NAMELY, SUBSTANCES FOR THE TREATMENT AND PREVENTION OF DISEASES OF THE CENTRAL NERVOUS SYSTEM AND TO ASSIST IN THE CESSATION OF USE OF TOBACCO PRODUCTS;